Home Proteros biostructures

Proteros biostructures

In operation
Equity Financing
Early Drug Discovery Service Provider
Basic
Enterprise Profile

Basic Information

Proteros biostructures GmbH is a privately-owned early-stage drug discovery service provider dedicated to helping pharmaceutical and biotechnology companies unlock even the most challenging drug targets. A pioneer in the industrialization of structural biology, Proteros has developed a cutting-edge drug discovery platform encompassing protein science, protein crystallography, cryo-electron microscopy, analytics, biophysics, and screening, positioned to open doors for technically demanding targets and lead optimization and clinical programs.
Proteros biostructures GmbH
Germany
51~100 people
January 01, 1998
--

Enterprise Profile

Industrial Sector
New Drug Development Information Technology Vendors Scientific Research and Experimental Development Services CRO
Technology
Targeted Technology
Application Scenarios
Innovative Drugs